ad

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Which Stock Should You Track

Vijaya Diagnostic MCap Rs 14,309 Cr, PE 82.74x, ROE 18.07%, D/E 0.44. Krsnaa Diagnostics MCap Rs 1,815 Cr, PE 17.90x, ROE 10.35%, D/E 0.55.


10 Aug 202610:46 am

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Which Stock Should You Track

Vijaya Diagnostic Centre vs Krsnaa Diagnostics is a comparison investors look up when evaluating two listed Indian diagnostic lab companies with very different business models. Vijaya Diagnostic Centre is a premium Hyderabad-based diagnostics chain operating consumer-facing collection centres and labs for B2C pathology and radiology, while Krsnaa Diagnostics is a B2G (business-to-government) diagnostics company operating diagnostic labs at government hospitals under public-private partnership (PPP) contracts across multiple states.

This Vijaya Diagnostic Centre vs Krsnaa Diagnostics article covers reach and market position, key products, latest declared results and stock valuation. The Vijaya Diagnostic Centre vs Krsnaa Diagnostics data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Reach and Market Position

On the Vijaya Diagnostic Centre side of the Vijaya Diagnostic Centre vs Krsnaa Diagnostics comparison, Vijaya Diagnostic operates over 220 centres across Telangana, Andhra Pradesh and adjacent states, serving paying retail patients through its own chain. Market capitalisation is Rs 14,309 Cr.

Click Here – Get Free Investment Predictions

On the Krsnaa Diagnostics side of the Vijaya Diagnostic Centre vs Krsnaa Diagnostics comparison, Krsnaa Diagnostics operates labs installed at government hospitals across Maharashtra, Punjab, Rajasthan, Karnataka and other states under PPP contracts. Market capitalisation is Rs 1,815 Cr.

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Key Products and Business Mix

In the Vijaya Diagnostic Centre vs Krsnaa Diagnostics product comparison, Vijaya Diagnostic Centre offers: Vijaya Diagnostic earns from pathology tests, radiology (CT, MRI, PET-CT) and preventive health packages at retail diagnostic centres. EPS is Rs 16.79. P/E is 82.74x, ROE 18.07 percent, D/E 0.44.

For Krsnaa Diagnostics in this Vijaya Diagnostic Centre vs Krsnaa Diagnostics breakdown: Krsnaa earns from government-contracted diagnostic tests at PPP labs. EPS is Rs 31.27. P/E is 17.90x, ROE 10.35 percent, D/E 0.55. Krsnaa is roughly 8 times smaller than Vijaya by market cap.

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Latest Results

The Vijaya Diagnostic Centre vs Krsnaa Diagnostics results for Vijaya Diagnostic Centre: Vijaya Diagnostic has a market cap of Rs 14,309 Cr and P/E of 82.74x. ROE is 18.07 percent. Vijaya's premium valuation reflects its South India franchise strength and asset-light collection point model.

The Vijaya Diagnostic Centre vs Krsnaa Diagnostics results for Krsnaa Diagnostics: Krsnaa Diagnostics has a market cap of Rs 1,815 Cr and P/E of 17.90x. ROE is 10.35 percent. Krsnaa's low P/E relative to Vijaya reflects its B2G model with government payment risk and working capital intensity.

Compare Vijaya Diagnostic Centre and Krsnaa Diagnostics Fundamentals on the Univest Screener

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Stock and Valuation

The Vijaya Diagnostic Centre vs Krsnaa Diagnostics stock comparison uses the latest available market data from Groww. Investors tracking Vijaya Diagnostic Centre vs Krsnaa Diagnostics should verify current prices on NSE or BSE before trading.

Vijaya Diagnostic vs Krsnaa Diagnostics at current valuations: Vijaya trades at Rs 14,309 Cr market cap, P/E 82.74x, ROE 18.07 percent, D/E 0.44. Krsnaa trades at Rs 1,815 Cr market cap, P/E 17.90x, ROE 10.35 percent, D/E 0.55. Vijaya is far more expensive but operates a cash-generative B2C retail model. Krsnaa is cheap but faces government payment receivables risk.

Vijaya Diagnostic Centre vs Krsnaa Diagnostics: Quick Comparison Table

The Vijaya Diagnostic Centre vs Krsnaa Diagnostics comparison table below summarises the key metrics covered in this article side by side.

Parameter Vijaya Diagnostic Centre Krsnaa Diagnostics
Sector B2C diagnostics: Telangana and AP retail B2G diagnostics: PPP government hospital labs
Market Cap Rs 14,309 Cr Rs 1,815 Cr
P/E Ratio 82.74x 17.90x
ROE 18.07% 10.35%
Debt to Equity 0.44 0.55
Revenue Model Retail consumer payments Government PPP contracts
Geography Hyderabad and South India Multi-state (Maharashtra, Punjab, etc.)

Conclusion

The Vijaya Diagnostic Centre vs Krsnaa Diagnostics comparison above covers the key data points on reach, products, results and valuation. Vijaya Diagnostic vs Krsnaa Diagnostics covers two distinct diagnostics business models — premium B2C retail labs and B2G PPP government labs. Vijaya is valued at a premium for its South India consumer brand strength and ROE. Krsnaa offers value pricing but carries concentration risk from government contracts and payment delays. Investors should review revenue per centre, test volume growth, government receivables days and new centre additions before taking a view. Consult a SEBI-registered advisor for personalised guidance.

Download the Univest iOS App or Univest Android App to track Vijaya Diagnostic Centre and Krsnaa Diagnostics live price and get daily stock recommendations.

SEBI Research Analyst Registration No. INH000013776

Frequently Asked Questions

What is Vijaya Diagnostic Centre known for?

Ans. Vijaya Diagnostic Centre is a leading South Indian diagnostics chain known for its full-service pathology and radiology at collection centres in Hyderabad. It is highly regarded for PET-CT, MRI and advanced pathology.

What is a PPP diagnostic lab?

Ans. A PPP (Public-Private Partnership) diagnostic lab is set up by a private company inside a government hospital under a contract from the state or central government. The company provides diagnostic services to government hospital patients at subsidised rates, recovering costs through the contract.

Does Vijaya Diagnostic operate outside Hyderabad?

Ans. Yes. Vijaya Diagnostic has expanded beyond Hyderabad into Telangana, Andhra Pradesh and a few other states, though its core strength remains South India.

Is Krsnaa Diagnostics a good investment?

Ans. Krsnaa's government contract model brings revenue visibility but also payment risk. Investors should review receivables days, contract renewals and margin profile. Consult a SEBI-registered advisor.

What is the difference between pathology and radiology in diagnostics?

Ans. Pathology involves lab tests on blood, urine, tissue samples etc. Radiology involves imaging — X-ray, CT scan, MRI, PET-CT. Large diagnostic chains like Vijaya Diagnostic offer both.

Are Vijaya and Krsnaa in Nifty 50?

Ans. Neither is in Nifty 50. Both are tracked in Nifty Healthcare and smaller indices.

Does Vijaya Diagnostic pay dividends?

Ans. Vijaya Diagnostic pays a very small dividend yield of approximately 0.14 percent.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down